Friday, March 25, 2016

Today's GIST

1. Standard treatment
is Imatinib for 3 years for patient with high risk of recurrence
those with Exon 11 in the KIT gene will respond the best

2.The 2nd line is Sunitinib
3.Those who resist these meds, well Regorafenib may work
check your FDA recommended list

No comments: